Management of Classic Ulcerative Pyoderma Gangrenosum

被引：7

作者：

Afifi, Ladan ^{[1
]}

Ortega-Loayza, Alex G. ^{[2
]}

Shinkai, Kanade ^{[3
]}

机构：

[1] Univ Calif Los Angeles, Dept Dermatol, Los Angeles, CA USA

[2] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA

[3] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA

来源：

CUTIS | 2020年 / 106卷 / 03期

关键词：

D O I：

10.12788/cutis.0076

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis with unclear etiology and is associated with notable morbidity. Due to the rarity of PG, there are limited large, multicentered, randomized trials to guide management. We aim to highlight best practices in PG management through survey responses from expert medical dermatologists.

引用

页码：119 / +

页数：7

共 12 条

[1] Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts [J].

Al Ghazal, Philipp ;

Dissemond, Joachim .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (04) :317-325

[2] Diagnostic criteria for pyoderma gangrenosum: results of a survey among dermatologic wound experts in Germany [J].

Al Ghazal, Philipp ;

Klode, Joachim ;

Dissemond, Joachim .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 (12) :1129-1131

[3] The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum [J].

Ashchyan, Hovik J. ;

Butler, Daniel C. ;

Nelson, Caroline A. ;

Noe, Megan H. ;

Tsiaras, William G. ;

Lockwood, Stephen J. ;

James, William D. ;

Micheletti, Robert G. ;

Rosenbach, Misha ;

Mostaghimi, Arash .

JAMA DERMATOLOGY, 2018, 154 (04) :409-+

[4] A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions [J].

Bennett, ML ;

Jackson, JM ;

Jorizzo, JL ;

Fleischer, AB ;

White, WL ;

Callen, JP .

MEDICINE, 2000, 79 (01) :37-46

[5] Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients [J].

Binus, A. M. ;

Qureshi, A. A. ;

Li, V. W. ;

Winterfield, L. S. .

BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) :1244-1250

[6] Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial [J].

Brooklyn, TN ;

Dunnill, MGS ;

Shetty, A ;

Bowden, JJ ;

Williams, JDL ;

Griffiths, CEM ;

Forbes, A ;

Greenwood, R ;

Probert, CS .

GUT, 2006, 55 (04) :505-509

[7] Pyoderma gangrenosum: A review and update on new therapies [J].

Miller, Jeremiah ;

Yentzer, Brad A. ;

Clark, Adele ;

Jorizzo, Joseph L. ;

Feldman, Steven R. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (04) :646-654

[8] Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial [J].

Ormerod, Anthony D. ;

Thomas, Kim S. ;

Craig, Fiona E. ;

Mitchell, Eleanor ;

Greenlaw, Nicola ;

Norrie, John ;

Mason, James M. ;

Walton, Shernaz ;

Johnston, Graham A. ;

Williams, Hywel C. .

BMJ-BRITISH MEDICAL JOURNAL, 2015, 350

[9] Pyoderma gangrenosum: Classification and management [J].

Powell, FC ;

Su, WPD ;

Perry, HO .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (03) :395-409

[10] Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients [J].

Reichrath, J ;

Bens, G ;

Bonowitz, A ;

Tilgen, W .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (02) :273-283

← 1 2 →